On January 10, 2021 Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in class therapeutics in hematology and oncology, reported that it will participate in the 39th Annual J.P. Morgan Healthcare Conference, which is the largest healthcare investment symposium in the industry (Press release, Antengene, JAN 10, 2021, View Source [SID1234573763]). Dr. Jay Mei, Founder, Chairman and CEO of Antengene, will present a corporate overview on Monday, January 11, 2021 at 8:40 a.m. EST (Monday, January 11, 2021 at 9:40 p.m. BJT).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Antengene Corporation Limited (SEHK: 6996.HK)
Date: Monday, January 11
Time: 8:40 a.m. EST
Presenter: Dr. Jay Mei, M.D., Ph.D., Antengene’s founder, chairman and chief executive officer
Webcast: View Source;kiosk=true